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Abstract Short-term (1 h) exposure of cells to a low steady-
state concentration of H2O2 causes no immediate cell death but
apoptosis occurs several hours later. This delayed cell death may
arise from activation of phospholipases, in particular phospho-
lipase A2 (PLA2), which may destabilize lysosomal and
mitochondrial membranes. Indeed, the secretory PLA2 (sPLA2)
inhibitor 4-bromophenacyl bromide diminishes both delayed
lysosomal rupture and apoptosis. Furthermore, sPLA2 activation
by mellitin, or direct micro-injection of sPLA2, causes lysosomal
rupture and apoptosis. Finally, B-cell leukemia/lymphoma 2
(Bcl-2) over-expression prevents oxidant-induced activation of
PLA2, delayed lysosomal destabilization and apoptosis. This
supports a causal association between PLA2 activation and
delayed oxidant-induced cell death and suggests that Bcl-2 may
suppress apoptosis by preventing PLA2 activation. ß 2001
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Cultured cells transiently exposed to very low concentra-
tions of oxidants do not immediately die but do undergo ap-
optosis several hours later [1,2]. The processes which occur
during this interesting delay are unknown as are the very ear-
liest events in apoptosis. Of course, delayed apoptotic cell
death caused by other agonists, such as serum or growth
factor withdrawal, is well described. In many cases, such as
apoptosis of neuronal cells triggered by withdrawal of nerve
growth factor, there is a stringent requirement for protein
synthesis [3], which helps to explain the delay in apoptosis.
In the particular case of oxidant-induced apoptosis, it has
been previously suggested that an important upstream event
in this process may be the destabilization of lysosomes with
release of their potent digestive enzymes into the cell cyto-
plasm [4^8]. When cultured cells are exposed to minimally
e¡ective doses of pro-apoptotic agents such as H2O2, the pro-
cess of lysosomal leakage appears to occur in two phases: an
early and minor lysosomal destabilization followed some time
later by a more massive lysosomal rupture and apoptosis
[1,2,9]. This occurs even if the oxidant is removed after only
a brief period but the processes involved in this delayed lyso-
somal rupture and apoptosis are presently unknown.
We hypothesized that this delayed oxidant-mediated cell
death might be related to a progressive destabilization of
the membranes of intracellular organelles, such as might be
e¡ected by the degradation of phospholipids by phospholi-
pases. Several neurodegenerative conditions, such as Alzheim-
er’s disease, stroke and spinal cord trauma, have been re-
ported to involve activation of phospholipases [10].
Moreover, activation of phospholipase A2 (PLA2) has been
observed in apoptosis triggered by agonists such as tumor
necrosis factor and oxidative stress [11,12]. This raises the
possibility that delayed cell death following oxidant challenge
might similarly involve activated PLA2 which, in turn, could
progressively destabilize the membranes of organelles, such as
lysosomes and mitochondria, either through simple depletion
of phospholipid from organellar membranes, or through the
accumulation of chaotropic products, such as free fatty acids
or lysophosphatides. The resulting rupture of these organelles
would then constitute a sort of auto-digestive ‘death spiral’
culminating in delayed apoptosis.
We have, therefore, tested the possibility that the leakage of
lysosomal contents might be associated with activation of
PLA2. Here, we report evidence that PLA2 activation is in-
timately involved in delayed oxidant-induced lysosomal rup-
ture and ensuing apoptosis, providing a possible explanation
for the slow appearance of cell death following even brief
exposure to low levels of oxidants.
2. Materials and methods
2.1. Materials
Chemicals were purchased from Sigma (St. Louis, MO, USA) un-
less otherwise indicated. RPMI 1640 medium, fetal bovine serum,
glutamine, penicillin, and streptomycin were obtained from Gibco
BRL (Grand Island, NY, USA). The CaspACE FITC-VAD-FMK
In Situ Marker was purchased from Promega Corporation (Madison,
WI, USA), while the liposomal delivery vehicle, N-[1-(2,3-dioleoyl)-
propyl]-N,N,N-trimethyl-ammonium salt (DOTAP), was obtained
from Boehringer Mannheim (Indianapolis, IN, USA). PLA2 (P6534)
was from Sigma. The plasmid (murine) B-cell leukemia/lymphoma 2
(Bcl-2)K/pMKITNeo, was a kind gift from Dr. W.S. May, University
of Texas Medical Branch, Galveston, TX, USA.
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2.2. Cell cultures
J774 cells (a murine histiocytic lymphoma cell line) and AG-1518
cells (a human foreskin ¢broblast cell strain) were maintained in
RPMI 1640 medium supplemented with 10% fetal bovine serum,
2 mM glutamine, 50 U/ml penicillin, 50 Wg/ml streptomycin and 1%
non-essential amino acids. Cells were maintained in plastic £asks and
sub-cultivated at con£uence twice a week. Medium was changed daily.
For experiments, cells were transferred into 35 mm six-well plates
(5U105 cells/well) 24 h before use.
2.3. Over-expression of Bcl-2
J774 cells were sub-cultivated and grown in six-well plates (5U105
cells/well) as described above. The cells were transfected with Bcl-2K/
pMKITNeo expression plasmids, which contain a neomycin resistance
element, using liposomal delivery by DOTAP according to the man-
ufacturer’s directions. Ten clones of stably transfected cells were se-
lected by their neomycin resistance. Bcl-2 expression levels were as-
sayed by Western blot analysis (vide infra). Compared to the parental
J774 cells, three clones of the transfected cells had at least a ¢ve-fold
increase of immuno-reactive Bcl-2 protein [1] and one of these was
chosen for further experiments. The Bcl-2 over-expressing J774 cell
line is hereafter termed ‘J774-Bcl-2’.
2.4. Pre-treatment of cells with desferrioxamine (Des)
In some experiments, J774 cells were pre-treated with 1 mM (¢nal
concentration) Des for 1 h at 37‡C in complete medium. The cells
were then rinsed and incubated in complete medium under standard
culture conditions (without Des) for another 30 min and, ¢nally, ex-
posed to H2O2 as described below.
2.5. Exposure to H2O2
Parenteral J774 cells and J774-Bcl-2 cells, cultured in six-well plates
(5U105 in 2 ml of complete medium) as described above, were ex-
posed for 1 h at 37‡C to a steady-state concentration (40 WM) of
H2O2 as described previously [1,2,13]. To abruptly obtain this
steady-state concentration of H2O2, 37 mU/ml glucose oxidase (1.5
Wg/ml) was added together with an initial bolus of H2O2 to bring the
starting H2O2 concentration to 40 WM. Following 1 h of oxidative
stress, under otherwise standard culture conditions, catalase was
added to clear the H2O2, and the medium was replaced (but not
when medium was assayed for arachidonic acid (AA) release, see
below).
2.6. Lysosomal stability assessment by acridine orange (AO)
Cells were assessed for lysosomal stability using the (i) AO uptake
and (ii) AO relocation methods as previously described [1,2,14]. The
number of remaining intact lysosomes was evaluated by assaying red
£uorescence (AO uptake method) following AO-staining of the cells at
particular times after exposure to oxidative stress. To detect early and
minor lysosomal destabilization, the progressive release of AO from
cells which had been pre-incubated with AO prior to oxidant chal-
lenge was monitored (the AO relocation method). AO £uorescence
was measured by £ow cytometry using a Becton-Dickinson FACScan
(Becton-Dickinson, Mountain View, CA, USA) equipped with a 488
nm argon laser. Cells were detached by scraping with a rubber police-
man and collected for £ow cytometric assessment of red (AO uptake)
or green (AO relocation) £uorescence.
2.7. Assessment of apoptosis
1. The DNA fragmentation associated with apoptosis was followed
using propidium iodide staining of nuclear DNA (the ‘Nicoletti’
assay) as described elsewhere [15].
2. Caspase activation associated with apoptosis was evaluated by mi-
croscopic analysis of living cells stained according to the manufac-
turer’s directions with a FITC-conjugated broad spectrum inhibitor
of caspases, CaspACETM FITC-VAD-FMK In Situ Marker, that
irreversibly binds to activated caspases. Brie£y, cells were seeded at
5U105 cells/ml, exposed to H2O2 as described above, and then
incubated under standard culture conditions for another 4 h. The
marker was then added to the medium at a ¢nal concentration of
10 WM and the cells were incubated in the dark for 20 min, rinsed
three times (5 min in total) in phosphate-bu¡ered saline (PBS; 20
mM Na3PO4, 130 mM NaCl, pH 7.4) and observed, counted and
photographed using a Nikon £uorescence microscope.
2.8. Measurement of 3H-AA release
To assess intracellular activation of phospholipases, cells were pre-
labeled with 1.5 WCi/ml 3H-AA and incubated in serum-free medium
at 37‡C for 18 h, as previously described [16]. Unincorporated 3H-AA
was removed by washing (U3) with PBS. Cells were then resuspended
in fresh serum-free medium containing 1% fatty acid-free albumin in
24-well plates in triplicate and incubated for another 5 h to let the
cells attach well to the plates, exposed to H2O2 as described above,
and then kept under normal culture conditions for di¡erent periods of
time. Medium was not changed (in order to preserve any released AA)
and catalase (90 U/ml) was added to stop further exposure to H2O2
following the 1 h period of oxidative stress.
For measurements of AA release, we used a procedure designed to
avoid artifactual detection of 3H-AA which might be associated with
the very small membrane blebs typically produced by cells undergoing
apoptosis. Cells and insoluble material such as larger membrane frag-
ments were pelleted by centrifugation at 13 000Ug for 10 min. The
supernatant was then chromatographed on Cibracron blue 3GA-aga-
rose and retained radioactivity (representing free 3H-AA bound to the
albumin) was eluted using 0.1 M guanidine^HCl. Total radioactivity
in the starting cells and in the eluted liquids was measured by scintil-
lation counting. The total incorporation of 3H-AA into cell mem-
brane phospholipids was also measured by scintillation counting (val-
ue A) and the percentage of radioactivity released into the medium
and bound by albumin (value B) was expressed as the ratio of
B/AU100.
2.9. Micro-injection of PLA2
Micro-injection of the ¢broblast cell strain, AG-1518, with puri¢ed
sPLA2 was performed on the stage of a Zeiss Axiovert (Gena, Ger-
many) inverted microscope using an Eppendorf pressure injector
(model 5246) and a micro-manipulator (‘Injectman0’). Micro-injec-
tion needles (Femtotips II; Eppendorf, Hamburg, Germany) with
an inner diameter of less than 0.5 Wm were loaded using Eppendorf
micro-loaders. All injectates were freshly prepared and contained
5 U/ml sPLA2 as well as 1 mg/ml dextran-conjugated Texas Red in
PBS (pH 7.4) as a tracer. The solution was injected into the cytoplasm
of individual cells at a pressure of 100 h Pa, with an injection time of
Fig. 1. Inhibition of PLA2 and Bcl-2 over-expression block the sec-
ond phase of oxidant-induced lysosomal rupture. J774 and J774-Bcl-
2 cells were pre-stained with AO as described in Section 2, then ex-
posed to a low steady-state concentration of H2O2 and periodically
analyzed by £ow cyto£uorometry for green AO-induced £uorescence
(representing the appearance of previously lysosomal AO in the cell
cytoplasm-relocation AO method) at indicated periods of time. The
results are presented as percentage of values before the initiation of
oxidative stress. Each point represents the mean þ 1S.D. of triplicate
determinations. All points for the Des curve are statistically di¡erent
(P6 0.01) from each of those for the J774, J774-BPB, and J774-Bcl-
2, while only the time points beyond 15 min di¡er between J774
and J774-Bcl-2, and between J774 and J774-BPB (P6 0.01 in both
cases).
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1.5 s. Injections were performed on 100^200 cells in each dish for each
experimental condition. Control cells received Texas Red only. Data
presented are representative of results obtained with at least three
separate dishes. Note that the purity of this preparation of sPLA2
was assayed by SDS^PAGE electrophoresis and s 95% was present
at the 14 kDa band (as determined by densitometric scanning) (not
shown).
2.10. Preparation of hepatic lysosomes
Livers were removed from 160^200 g female Wistar rats, homoge-
nized in 9 volumes of 0.3 M sucrose and centrifuged at 450Ug for 10
min. The supernatants were again centrifuged at 3500Ug for 10 min,
the pellet discarded, and the lysosome-containing supernatant centri-
fuged at 10 000Ug for 10 min. The pellets were washed and re-cen-
trifuged at 10 000Ug for 10 min, and resuspended in the sucrose bu¡-
er to a protein concentration of V15 mg/ml. The resultant lysosome
enriched fraction (LEF) was found to be stable in the homogenization
bu¡er at 4‡C for up to 4 h.
2.11. Enzymatic detection of lysosomal integrity
The e¡ects of sPLA2 on the integrity of lysosomes in the LEF
preparation were assessed by measurement of the release of L-galac-
tosidase. LEF (200 Wl) was incubated with sPLA2 (0.2 U/ml) for
various periods of time and then centrifuged at 14 000Ug for 10
min. The supernatants were removed and 1 ml distilled water with
Triton X-100 (¢nal concentration 1%) was added to the pellets to
cause lysis of the remaining intact lysosomes. The sediment (intra-
lysosomal) and supernatant (released) activities of L-galactosidase
were measured as described previously [17]. The results were expressed
as percentage of total L-galactosidase released.
The integrity of lysosomes within individual cells micro-injected
with sPLA2, was estimated by staining to cytoplasmic acid phospha-
tase activity (which is usually restricted to the lysosomal compart-
ment). Fibroblast AG-1518 cells in 35 mm plastic Petri dishes were
micro-injected with sPLA2 as described above and then kept under
standard culture conditions for 1 h. The cultures were brie£y rinsed in
0.25 M sucrose in 0.01 M Tris^HCl bu¡er (pH 7.4) at 37‡C and ¢xed
in 4% formaldehyde in 0.15 M Na cacodylate bu¡er, pH 7.4. Cultures
were incubated at 37‡C for 45 and 60 min with continuous agitation
in a modi¢ed Gomori type medium containing 0.22 M sucrose and
10% DMSO [18]. Following rinsing in 0.1 M cacodylate bu¡er with
0.1 M sucrose (pH 7.2; 300 mOsm), the reaction product was visual-
ized with 1% ammonium sulphide. The cultures were air-dried and
mounted under coverslips in immersion oil.
2.12. Statistical analysis
All experiments were repeated at least three times. Data are pre-
sented as arithmetic means þ 1S.D. Statistical signi¢cance of di¡eren-
ces between groups were determined using Student’s two-tailed t-test.
3. Results and discussion
Cells brie£y exposed to oxidative stress, in the form of low
steady-state concentrations of H2O2, do not die immediately
Fig. 3. Both oxidant stress and mellitin activate intracellular phos-
pholipase(s), and Bcl-2 over-expression suppresses this activation.
J774 and J774-Bcl-2 cells were pre-labeled with 3H-AA and then ex-
posed to oxidative stress for 1 h or to 0.5 WM mellitin for 3 h. The
cells were then incubated under standard culture conditions for the
indicated periods of time. Results shown represent mean þ 1S.D. of
triplicate determinations.
Fig. 2. Inhibition of sPLA2 and Bcl-2 over-expression block longer
term oxidant-induced lysosomal rupture, whereas it is promoted by
mellitin-induced PLA2 activation. J774 cells and J774-Bcl-2 cells
were exposed to oxidative stress for 1 h, or to 0.5 WM mellitin for
3 h, as described in Section 2. After exposure to oxidative stress, or
to mellitin, the cells were incubated under standard culture condi-
tions for another 8 h, and then stained by AO and analyzed for red
£uorescence (AO uptake method) by £ow cyto£uorometry as de-
scribed in Section 2. Representative results from at least triplicate
experiments are shown.
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yet undergo apoptosis several hours later [1,2]. This delayed
cell death is paralleled or, perhaps, preceded, by slow, pro-
gressive lysosomal rupture. Whereas only limited lysosomal
destabilization is observed during the actual exposure to oxi-
dative stress, a much more prominent rupture occurs several
hours after return of the cells to standard culture conditions
[1,2]. The early phase is probably a direct result of the oxidant
stress and may be explained by preferential oxidant damage to
the lysosomal compartment which is known to be particularly
rich in low molecular weight, redox-active iron. In contrast,
the second phase, which is inhibited by over-expression of Bcl-
2 [1,9] may involve secondary actions of the released lysoso-
mal enzymes which may promote further lysosomal rupture.
We hypothesized that activation of cellular phospholipases,
especially PLA2, might be involved in this second phase.
PLA2 attack on the membranes of intracellular organelles
such as lysosomes and mitochondria might explain both the
progressive lysosomal destabilization and ultimate cell death
which occur long after the oxidant challenge is removed.
In partial support of this hypothesis, inhibition of PLA2
(probably sPLA2) with 4-bromophenacyl bromide (BPB) ap-
pears to block preferentially the secondary phase of lysosomal
destabilization (i.e. that which occurs more than 30 min fol-
lowing initiation of oxidant challenge). Interestingly, similar
suppression of lysosomal AO release was seen in the cell line
over-expressing Bcl-2 (Fig. 1). The protective e¡ect of BPB
and Bcl-2 over-expression persisted over a period of at least
8 h (Fig. 2). However, note that neither BPB pre-treatment
nor Bcl-2 over-expression had signi¢cant e¡ect on the primary
phase of lysosomal destabilization (whereas pre-treatment of
cells with Des, known to localize almost exclusively within the
lysosomal compartment [2,19,20], had the expected protective
e¡ect on both phases of lysosomal rupture) (Fig. 1).
These observations suggested a possible causal relationship
between intracellular PLA2 activity and lysosomal destabili-
zation. Therefore, under identical experimental conditions, we
measured the release of 3H-AA from cells previously labeled
with this isotope. 3H-AA is presumed to be incorporated into
membrane phospholipids, preferentially in the sn-2 position
which is selectively hydrolyzed by PLA2. There were no di¡er-
Fig. 5. Micro-injection of sPLA2 induces lysosomal leak and ensuing apoptosis. AG1518 ¢broblasts were micro-injected with sPLA and then
incubated under standard culture conditions for another 2 h before cyto-chemical staining for acid phosphatase. A: Control cells. B: sPLA2-ex-
posed cells. Apoptotic cells were assayed after 3 h by the CaspACE1 FITC-VAD-FMK In Situ Marker staining. C: Control cells injected only
with Texas Red Tracer (green-light excitation). D: Control cells (blue-light excitation to show the FITC-conjugated caspase inhibitor).
E: sPLA2 micro-injected cells (green-light excitation). F: sPLA2 micro-injected cells (blue-light excitation). Representative examples are shown
from experiments done at least in triplicate. For all treatments, at least 100 cells were examined in each experiment.
Fig. 4. Lysosomes are destabilized by sPLA2. LEFs (0.6 mg/ml)
were incubated with sPLA2 (0.2 U/ml) for the indicated periods of
time and sedimentable and unsedimentable activity of L-galactosi-
dase (GAL) was measured. Results shown represent mean þ 1S.D.
of triplicate determinations.
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ences in the release of 3H-AA following the 1 h exposure to
oxidative stress but, over the following 8 h period, PLA2
activity increased signi¢cantly as judged by AA release (Fig.
3). Because our experimental conditions were designed to de-
tect only free 3H-AA release (as opposed to the production of
small membrane fragments known to form during apoptosis),
we are fairly con¢dent that these results do re£ect intracellular
PLA2 activation.
In order to further test whether PLA2 activity might, in
fact, be responsible for the delayed lyosomal rupture follow-
ing oxidant challenge, we employed semi-puri¢ed rat liver
lysosomes. Indeed, as judged by both £ow cytometry (results
not shown) and the release of lysosomal L-galactosidase ac-
tivity, puri¢ed sPLA2 causes almost total lysosomal disrup-
tion over a period of 2 h (Fig. 4).
To determine whether PLA2 was, by itself, su⁄cient to
Fig. 6. Inhibition of sPLA2 or Bcl-2 over-expression make cells resistant to oxidant-induced apoptosis. J774 and J774-Bcl-2 cells were exposed
to oxidative stress for 1 h, or to 0.5 WM mellitin for 3 h, and then kept under standard culture conditions for another 8 h (A) or 2 h (B), re-
spectively. The cells were then assayed for apoptosis by the Nicoletti technique (A) or with CaspACE1 FITC-VAD-FMK In Situ Marker to
determine caspase activation (B). n.s., no signi¢cant di¡erences from non-oxidant exposed cells; ***P6 0.001. Representative examples from at
least three independent experiments are shown.
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initiate both lysosomal destabilization and ensuing apoptosis,
sPLA2 was micro-injected into AG1518 cells. As shown in
Fig. 5, 2 h following the injection of sPLA2 there was a
pronounced loss of lysosomal integrity as judged by the re-
lease of acid phosphatase activity from its normal intralyso-
somal location (Fig. 5A,B). Furthermore, 3 h after the micro-
injection of sPLA2, there was substantial activation of cas-
pases as estimated by enhanced binding of the FITC-conju-
gated caspase inhibitor (Fig. 5F).
As additional evidence for a possible causal relationship
between PLA2 activation, lysosomal rupture and apoptosis,
pre-treatment of J774 cells with the PLA2 inhibitor BPB
greatly decreased the numbers of apoptotic cells appearing
8 h following oxidant challenge (Fig. 6A). This protection co-
incides with the suppression of both lysosomal leakage and
PLA2 activation reported above. Furthermore, cells treated
with an activator of endogenous PLA2, mellitin, also became
apoptotic after 8 h of further incubation (Fig. 6A). Mellitin
treatment was also associated with both lysosomal destabili-
zation and, as expected, activation of intracellular PLA2. Fi-
nally, as shown in Fig. 6B, caspase activation showed a sim-
ilar pattern, being induced by both mellitin or H2O2 exposure
and, in the latter case, being prevented by BPB pre-treatment.
The identity of the isoform(s) of PLA2 which might be
activated by mild oxidant stress remains unknown. There
are at least eight known isoforms of PLA2, broadly divided
into two classes, secretory (or sPLA2) and cytoplasmic (or
cPLA2), with the latter class being sub-divided into calcium-
dependent and -independent types. Given that inhibitors with
absolute speci¢city for these various isoforms are not now
available, we are unable to identify those most likely respon-
sible. However, the suppression of endogenous PLA2 activa-
tion, lysosomal rupture and apoptosis by BPB would support
the tentative conclusion that activation of sPLA2 may be
responsible inasmuch as this inhibitor is claimed to be rela-
tively speci¢c for this class [21].
Assuming that PLA2 activation is, indeed, causally involved
in the delayed apoptosis following oxidant challenge (and,
perhaps, apoptosis caused by other agonists), the mechanisms
directly involved in this process are not yet clear. The possi-
bilities include simple depletion of phospholipid from the bi-
layers of intracellular organelles such as lysosomes and mito-
chondria, leading to insu⁄cient remaining phospholipid to
constitute a stable bilayer. Alternatively, the products of
PLA2 attack on phospholipid, lysophosphatides and free fatty
acids which are known to have chaotropic and detergent ac-
tions, may be primarily responsible for lytic destruction of
organellar membranes.
Overall, our results suggest that the activation of PLA2
arises from partial lysosomal rupture, but it is not clear
whether PLA2 is directly activated by lysosomal enzymes or
if this activation is indirect. It was suggested that PLA2 may
be activated by caspases [22], which, in turn, may be activated
by lysosomal proteases [6]. The apparent suppression of PLA2
activation/activity by over-expression of Bcl-2 implies that this
well-known anti-apoptotic protein may exert its e¡ects
through previously unsuspected mechanisms. Indeed, Bcl-2
over-expression does somehow stabilize lysosomes against
the secondary, later phase of mild oxidative stress-induced
lysosomal rupture while, interestingly, having no e¡ect on
the short-term initial destabilization [1,9]. Such a downstream
mechanism of action is consistent with the general idea that
early lysosomal leakage itself leads to the later and much
more pronounced lysosomal rupture, perhaps by direct or
indirect activation of PLA2. By somehow interfering with
the activation, or activity, of PLA2, Bcl-2 (as well as inhib-
itors such as BPB) suppresses the second phase of lysosomal
rupture and the ensuing apoptotic process. We are hopeful
that more detailed knowledge of these intracellular events
may lead to more e¡ective pharmacologic intervention, per-
mitting the purposeful acceleration, or blockage, of apoptosis
which might be useful in diseases ranging from cancer and
neuro-degenerative diseases to in£ammation.
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